Nice post Ecomike- I knew Larry, the MVTG founder and CEO

New Post Public Reply Private Reply Replies (1) Message Board
Silver Boy
Nice post Ecomike-
I knew Larry, the MVTG founder and CEO with a vision, when and before MVTG was nearly dead, nearly lights out in Dec 2011, when things looked like they might not survive due to the world financial crisis US Congress was threatening default on US Debt) and rampant fear was loose in the market place (kinda like the recent Grexit but on a much larger scale). MVTG had no issued patents yet. No significant anti dilution investments were to be found. And Larry refused to use toxic debt financing.

The stock price had crashed to .01 and even to .0047 intraday, and I had already bought shares between .21 and .07 and in a one minute in dec 2011, a 250,000 share 1 minute dump by a dying cancer patient that was an early MVTG IPO investor crashed the price from .07 to .0047 and then it settled at .01 that day.

I and friends and family of mine bought all the MVTG shares we could at under .02 after that event.

Best investment I ever made.

Not long after that MVTG rallied to .08 then to .12 then .20 and then .30 in 2012. At that time I was up 3000%, but like today and the last 6 years I did not sell. I am in this for the long haul, the move to $5 to $10/share prices, like my other past picks have done. For example Mhan was at .001 that I bought the bottom on for 2 years, that is now near $19/share as Tgtx, another start up like MVTG with no sales. A biotech with less than MVTG has right now, except they have already uplisted like MVTG is planning to do to Nasdaq. Al they have is huge R&D costs for 10 years ahead of them and issued patents like MVTG

In 2014 MVTG rallied from .047/.06 (I got lucky and scored all the .06 shares at the bottom that day) to .75/.74 in three huge million share trade per day rallies. MVTG has a history of these rallies and is still in a 4 year long term rally to higher lows and higher highs.

New shares to fund MVTG were sold at prices as high as .40/share in 2014, $700,000 worth bought by old time private placement investors that had bought at .08 to .20 and they had options to buy more at .40, they bought all those options in 2014 at .40 not much over 12 months ago!!!!!

They bought restricted shares at .40!!!!! So these low prices today are screaming bargains right now, as MVTG has far more now to offer than they did then. MVTG now has the ERC patent issued in Canada and the MRFC fuel cell patent issued in the USA since the .40 shares were bought. Retail payed as much as .74/.75 on three rallies before these added assets were added to the MVTG success list. The $749,000 in Canadian grants have been added since then.

The Bavarian Germany brewery ERC-pilot plant has been added to the MVTG success list since then.

Completing the phase 2 and starting phase 3 of the MVTG-Alstom R&D revenue project has happened since then. That means MVTG is worth way more than .75/share now!!!!!

That means Alstom liked the R&D catalyst research results of Phase 2, as in it works for making syn gas so well that Alstom funded phase 3 and started phase 3!!!!

Phase three is just a plant design and costing exercise that should be entering phase 4 shortly. Phase 5 would be the beginning of an Alstom funded Pilot plant, maybe the German plant or a third Pilot plant (US DOE-Alston coal???) or both???

MVTG has since then (the low of Dec 2011) scored 6 issued patents,

5 more applied for in 2013 that are about to be published in print for all to see and read.

And MVTG has applied for many more patents as they mentioned in the recent PRs.

MVTG has received substantial funding from Alstom tied to their patents and the ERC technology.

MVTG has two ERC pilot plant agreements in place, one in Canada and one brand new one in Germany

MVTG has received over $749,000 in recent Canadian agency government grants. $449,000 in just one 2 year R&D grant. That is about 50 times the grant funding MVTG received since the 2008 IPO!!!!! Received just this year. Add in the nearly 1 million dollars that Alstom has already committed to MVTG and the 5-10 million Alstom could commit to in Phase 5 later this year and you have no excuse for not buying up these cheap MVTGs shares with spare cash.

I am buying more MVTG. I have been through far worse times with MVTG. My faith in MVTG and the CEO is not shaken one bit!!!!

High Wire Networks Inc. (HWNI) Stock Research Links

HWNI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 27

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 20

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 12

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 16

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 24

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Update on Danish Aerospace Company A/S Share Transactions

Updated Category News Views 262

Recent Share Transactions at Danish Aerospace Company A/S In a significant update for investors and stakeholders, Danish Aerospace Company A/S has announced recent transactions involving their shares by individuals in managerial positions and those closely associated with them. This announcement reflects compliance with the Market Abuse Regulation (EU) no. 596/2014,...

Continue Reading
Skanska's $57M Deal to Transform Del Mar Traffic

Updated Category News Views 15

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

Continue Reading
Understanding Home Depot's Options Trading: What’s Ahead?

Updated Category News Views 147

Home Depot's Recent Options Trading Activity Recent activities in the world of finance have caught the attention of investors and analysts alike, particularly surrounding Home Depot. Our examination of the options market has unveiled an intriguing trend with significant bearish movements. With a thorough dive into the options history of Home Depot (HD), we identified 35...

Continue Reading
Boardroom Styling Lounge Enhances Membership for Men's Grooming

Updated Category News Views 272

Boardroom Styling Lounge Introduces New Membership Plan Boardroom Styling Lounge, a prominent name in the men's grooming industry, has refreshed its membership program as part of its ongoing anniversary celebrations. This initiative reflects the company's dedication to adapting to the needs of modern men while maintaining exceptional service quality. Understanding...

Continue Reading
CNA Financial's Thriving Third Quarter Earnings Show Gains

Updated Category News Views 38

Key Financial Highlights for CNA Financial's Third Quarter CNA Financial Corporation (NYSE: CNA) has released its financial results for the third quarter of 2024, showcasing robust performance across various sectors. The net income reached a commendable $283 million, translating to $1.04 per share. This is a notable increase from the previous year's quarter, where the net...

Continue Reading